Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp EBIT Margin

The EBIT Margin (Operating Margin) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Sep 21, 2026 is 13.51 %. In the previous year, EBIT Margin (Operating Margin) was 8.56 % — a change of 57.72% (higher).

EBIT Margin

13.51 %

YoY

57.72%

Last updated:

EBIT Margin (Operating Margin) of Vcanbio Cell & Gene Engineering Corp is 2026 13.51 % . EBIT Margin (Operating Margin) of Vcanbio Cell & Gene Engineering Corp was 2025 8.56 % . It decreases by 57.72% higher compared to the previous year.

Vcanbio Cell & Gene Engineering Corp's operating (EBIT) margin stands at 13.5%, broadly stable from 14.3% several years earlier.

The Vcanbio Cell & Gene Engineering Corp EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
3.34 CNY
Jan 1, 2019
8.28 CNY
Jan 1, 2020
-7.03 CNY
Jan 1, 2021
14.32 CNY
Jan 1, 2022
10.03 CNY
Jan 1, 2023
8.25 CNY
Jan 1, 2024
8.56 CNY
Jan 1, 2025
13.51 CNY
The Vcanbio Cell & Gene Engineering Corp EBIT Margin history
YEAREBIT MarginYoY
13.51 %+57.72%
8.56 %+3.84%
8.25 %-17.79%
10.03 %-29.91%
14.32 %-303.71%
-7.03 %-184.87%
8.28 %+147.60%
3.34 %-29.57%
4.75 %-52.66%
10.03 %-71.82%
35.60 %+198.64%
11.92 %+121,575.46%
0.01 %-74.93%
0.04 %-80.95%
0.21 %+21.81%
0.17 %+145.71%
0.07 %-20.56%
0.09 %-27.08%
0.12 %+1,933.26%
0.01 %—
Access this data via the Eulerpool API
Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

EBIT Margin (Operating Margin) of Vcanbio Cell & Gene Engineering Corp is 13.51 % in 2026.

EBIT Margin (Operating Margin) of Vcanbio Cell & Gene Engineering Corp changed from 8.56 % to 13.51 %, representing a 57.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API
Get Free API Key

Margins — Vcanbio Cell & Gene Engineering Corp

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Vcanbio Cell & Gene Engineering Corp